多参数MRI用于胶质瘤分级:动态磁敏感对比、动态对比增强、扩散加权成像与MR波谱的头对头比较
回顾性纳入72例病理确诊胶质瘤患者(16例低级别、56例高级别),比较DSC、DCE、DWI和MRS鉴别高级别与低级别胶质瘤的诊断准确性。高级别胶质瘤的rCBV第95百分位、Ktrans第95百分位和Cho/Cr均高于低级别胶质瘤(P<0.01),rCBV第95百分位AUC最高(0.79),Ktrans第95百分位在IDH状态预测中AUC最高(0.73)。作者认为rCBV第95百分位可能最有助于区分高级别与低级别胶质瘤。
要点
- rCBV第95百分位鉴别高级别与低级别胶质瘤的AUC为0.79(95%CI 0.67-0.91)。
- Ktrans第95百分位预测IDH状态的AUC为0.73(95%CI 0.57-0.89)。
- ADC第5百分位和Cho/Cr的AUC分别为0.63和0.67,低于rCBV第95百分位。
核心结论
- rCBV第95百分位可能最有助于区分高级别与低级别胶质瘤,Ktrans第95百分位可能有助于预测弥漫性胶质瘤的IDH状态。
研究设计与样本
- 回顾性纳入72例病理确诊胶质瘤患者(16例低级别、56例高级别),对三维分割肿瘤行rCBV、Ktrans和ADC的直方图分析,MRS计算Cho/Cr,采用逻辑回归和ROC曲线分析。
诊断标准与关键数值
- rCBV第95百分位鉴别高级别(≥3级)与低级别(≤2级)胶质瘤的AUC为0.79(95%CI 0.67-0.91)。
- Ktrans第95百分位鉴别高级别与低级别胶质瘤的AUC为0.74(95%CI 0.59-0.88)。
- ADC第5百分位鉴别高级别与低级别胶质瘤的AUC为0.63(95%CI 0.48-0.79)。
- Cho/Cr鉴别高级别与低级别胶质瘤的AUC为0.67(95%CI 0.52-0.81)。
- IDH野生型胶质母细胞瘤与IDH突变型星形细胞瘤间rCBV第95百分位(P=0.04)和Ktrans第95百分位(P<0.01)有显著差异,Ktrans预测IDH状态的AUC最高(0.73,95%CI 0.57-0.89)。
临床应用与阅片要点
- 高级别胶质瘤的rCBV第95百分位、Ktrans第95百分位和Cho/Cr高于低级别胶质瘤(P<0.01)。
- rCBV第95百分位与Ktrans(ρ=0.47)、Cho/Cr(ρ=0.40)呈中度正相关,与ADC第5百分位(ρ=-0.36)呈中度负相关(均P<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the diagnostic accuracy of dynamic susceptibility contrast, dynamic contrast-enhancement, MR spectroscopy (MRS), and diffusion-weighted imaging for differentiating high-grade (HGGs) from low-grade gliomas (LGGs).
METHODS: Seventy-two patients (16 LGGs, 56 HGGs) with pathologically confirmed gliomas were retrospectively included. From three-dimensionally segmented tumor, histogram analyses of relative cerebral blood volume (rCBV), volume transfer constant (Ktrans), and apparent diffusion coefficient (ADC) were performed. Choline-to-creatinine ratio (Cho/Cr) was calculated using MRS. Logistic regression analyses were performed to differentiate HGGs (grade ≥ 3) from LGGs (grade ≤ 2). Areas under the receiver operating characteristics curves (AUC) were plotted. Subgroup analysis was performed between IDH-wildtype glioblastomas and IDH-mutant astrocytomas. Pairwise Spearman's correlation coefficients (ρ) were computed.
RESULTS: HGGs had higher 95th percentile rCBV, Ktrans and Cho/Cr (P < 0.01) than LGGs. AUC of 95th percentiles of rCBV and Ktrans were 0.79 (95% CI, 0.67-0.91) and 0.74 (95% CI, 0.59-0.88), respectively. AUC of 5th percentile of ADC was 0.63 (95% CI, 0.48-0.79), and that of Cho/Cr was 0.67 (95% CI, 0.52-0.81). IDH-wildtype glioblastomas and IDH-mutant astrocytomas showed significantly different 95th percentile rCBV (P = 0.04) and Ktrans (P < 0.01), with Ktrans showing the highest AUC (0.73, 95% CI 0.57-0.89) in IDH status prediction. Moderate correlations were observed between 95th percentile rCBV and Ktrans (ρ = 0.47), Cho/Cr (ρ = 0.40), and 5th percentile ADC (ρ = -0.36) (all P < 0.01).
CONCLUSIONS: The 95th percentile rCBV may be most helpful in discriminating HGGs from LGGs. The 95th percentile Ktrans may aid predicting IDH status of diffuse gliomas.
引用
- Seo, Choi, Soo Lee, et al. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy. Eur J Radiol. 2023. PMID: 37257338. doi:10.1016/j.ejrad.2023.110888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。